Literature DB >> 14605261

Validation of the direct nasopharyngeal sampling method for collection of expired air in preterm neonates.

Sophie R D van der Schoor1, Barbara A E de Koning, Darcos L Wattimena, Dick Tibboel, Johannes B van Goudoever.   

Abstract

In clinical studies, the oxidation of 13C-labeled substrates to 13CO2 and the measurement of the appearance of excess 13CO2 in expiratory air has progressed to an increasingly common method as it is noninvasive and lacks the radiation exposure associated with the use of 14C. The collection of respiratory CO2 currently used occurs via trapping of CO2 in sodium hydroxide (trapping method), sometimes in conjunction with indirect calorimetry. The aim of the present study was to determine the accuracy of our direct nasopharyngeal sampling method for the collection of breath samples in preterm infants compared with the currently used trapping method. We present a method that simplifies the collection of breath samples in preterm infants. Seven preterm infants with a gestational age of 26-29 wk were studied on different postnatal days (range, 8-52 d) while receiving full enteral feeding. A primed constant 3-h intragastric infusion of [13C]bicarbonate was given, and breath samples were collected by means of direct nasopharyngeal sampling and by a sodium hydroxide trap simultaneously. Breath CO2 isotopic enrichments rose rapidly to reach a plateau by 120 min with <5% variation of plateau in both methods. 13CO2 breath isotopic enrichments obtained by the direct nasopharyngeal sampling method correlated highly (r2 = 0.933; p < 0.0001) with the trapping method. The Bland-Altman analysis showed no significant variability between the two methods and demonstrated that the 95% confidence interval is within +/- 4.68 delta per thousand. These findings validate the simple method of direct nasopharyngeal sampling of expired air in neonates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605261     DOI: 10.1203/01.PDR.0000099792.66562.7E

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  The 1-13 C galactose breath test in GALT deficient patients distinguishes NBS detected variant patients but does not predict outcome in classical phenotypes.

Authors:  Mendy M Welsink-Karssies; Dewi van Harskamp; Sacha Ferdinandusse; Carla E M Hollak; Hidde H Huidekoper; Mirian C H Janssen; E Marleen Kemper; Janneke G Langendonk; M Estela Rubio-Gozalbo; Maaike C de Vries; Frits A Wijburg; Henk Schierbeek; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2020-01-22       Impact factor: 4.982

2.  Does a reduced glucose intake prevent hyperglycemia in children early after cardiac surgery? a randomized controlled crossover study.

Authors:  Carlijn T I de Betue; Sascha C A T Verbruggen; Henk Schierbeek; Shaji K Chacko; Ad J J C Bogers; Johannes B van Goudoever; Koen F M Joosten
Journal:  Crit Care       Date:  2012-10-02       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.